Theriogenology最新文献

The study investigated whether bacterial seeding occurs in utero in dogs and cats using a multi-technique approach, including 16S rRNA gene sequencing, culture, and fluorescence in situ hybridization (FISH). Healthy pregnant bitches and queens (n = 8) undergoing ovariohysterectomy between 30 and 45 days of gestation were included. Placenta and amniotic fluid samples from two foetuses per dam, along with multiple controls (uterine serosa, sampling table, and surgeon's gloves), were collected and analysed. Bacterial sequences were detected in all foetal samples, with no significant differences in intra- and inter-sample diversity (i.e., alpha and beta diversities, respectively) based on sample type or species. However, the surgeon's gloves showed species-specific differences in bacterial composition. After removing control sequences, significant differences based on foeto-maternal units emerged. Moraxella spp. was cultured from the canine placenta with the highest bacterial load, and Burkholderia cepacia was isolated from two feline placentae. FISH showed low bacterial presence in 50 % of placentae without histological signs of inflammation. No bacterial growth was observed in amniotic fluid or control samples. A multi-technique approach, including multiple controls, is essential in studies involving low-biomass samples, as the results of the present study indicated that contamination could mask real bacterial composition of foetal samples. After decontamination, differences were observed based on the foeto-maternal unit. This study confirmed the presence of bacterial DNA in placental and amniotic fluid samples during mid-term, healthy pregnancies in dogs and cats. Bacterial DNA is not equivalent to living bacteria, hence bacterial DNA fragments in the uterus probably originate from the dam but are unlikely to indicate the presence of a resident foetal microbiome.

Treatment with intra-vaginal progesterone pessaries for synchrony of estrus is essential in fixed-time artificial insemination (AI) of sheep. Globally, the conventional 14-day pessary treatment is the mainstay of commercial AI programs. It has remained largely unchanged for many decades even though it is associated with variable patterns of estrus and often disappointing pregnancy rates. Until recently, an understanding of this variability has been elusive. Here we review research of the last 25 years and conclude that synchronising estrus and obtaining satisfactory pregnancy rates (≥75 %) following AI is more challenging than expected from the original research of the 1960s. In particular, conventional pessary treatment is unable to control the time of emergence of the ovulatory follicle and the resultant variability in follicle age affects fertility. Additionally, the pessary is unable to mitigate the effects of season, nutrition and cyclical status of the ewe on the timing of estrus. It is concluded that the inability of pessary treatment to produce a uniform synchrony together with the adverse effects on follicle quality are primarily responsible for variable pregnancy rates. However, there are strategies to improve AI success rates. The first involves controlling the time of emergence of the ovulatory follicle so that it occurs primarily during the most fertile period of pessary treatment (Days 7-9 of a 14-day treatment). The second involves improving the synchrony of estrus by enhancing circulating levels of progesterone late (Day 9) in the treatment period. The third involves the use of short-term pessary treatments (5-7 days) that avoid some of the abnormalities associated with conventional treatment. Finally, given the variability in the timing of estrus, we address the challenge of optimising the time of insemination, an essential requirement of successful AI programs.

This study evaluated the effects of oral pentoxifylline on testicular biometry, histology, and gene expression in stallions subjected to scrotal heat stress. Fourteen stallions were divided into three groups: Control (CRL, n = 4), Testicular Degeneration (DEG, n = 5), and Testicular Degeneration Treated with Pentoxifylline (DEG + PTX, n = 5). Testicular degeneration was induced by scrotal insulation, twice daily, over two consecutive days (D-1 and D0). Starting the next day (D1), oral pentoxifylline (17 mg/kg) was administered every 12 h for 30 days. Testicular biometry was measured using a caliper from D-5 to D60. On days 30 and 60, testicular biopsies were collected for histopathology and gene expression analysis of BAX, CASP8, CASP9, FAS, HSF1, and PTGS2 using RT-qPCR. Pentoxifylline reduced histological damage, with the DEG + PTX group showing less pronounced basal lamina undulation and seminiferous tubule atrophy compared to the DEG group. However, it did not fully prevent lesions like germ cell vacuolization, which was reflected macroscopically by a reduction in testicular volume in both degenerated groups. The protective effects of pentoxifylline on testicular tissue can be attributed to its ability to reduce BAX expression, prevent CASP8 and CASP9 activation, and promote cellular protective mechanisms through HSF1 activation at D30. These results highlight pentoxifylline's potential as a therapeutic agent for equine testicular damage due to scrotal heat stress, suggesting the need for further research on optimal dosage and treatment duration.

Following a significant increase in herd and farm sizes after the removal of milk quotas in Europe, the past 10 years have seen a slight yet steady decline in the population of cattle. This includes a reduction of approximately 5 % in dairy and beef cattle. This trend is driven by various factors, such as changing market demands, economic shifts, and sustainability challenges in the livestock sector. Despite this, technological advancements in reproductive management have continued to enhance efficiency and sustainability, particularly in dairy production. The main areas of rapid development, which will continue to grow for improving fertility and management, include: i) genetic selection (including improved phenotypes for use in breeding programs), ii) nutritional management (including transition cow management), iii) control of infectious disease, iv) rapid diagnostics of reproductive health, v) development of more efficient ovulation/estrous synchronization protocols, vi) assisted reproductive management (and automated systems to improve reproductive management), vii) increased implementation of sexed semen and embryo transfer, viii) more efficient handling of substantial volumes of data, ix) routine implementation of artificial intelligence technology for rapid decision-making at the farm level, x) climate change and sustainable cattle production awareness, xi) new (reproductive) strategies to improve cattle welfare, and xii) improved management and technology implementation for male fertility. This review addresses the current status and future outlook of key factors that influence cattle herd health and reproductive performance, with a special focus on dairy cattle. These insights are expected to contribute to improved performance, health, and fertility of ruminants in the next 20 years.

This study compared the effect of a 7-day estradiol- and a 7-day GnRH-based FTAI protocol versus a presynchronized GnRH-based FTAI protocol (7 & 7 GnRH) on pregnancy per AI (P/AI) in multiparous postpartum Angus cows. Cows were blocked according to presence/absence of a CL, body condition score, and days postpartum and assigned randomly to one of three treatments: I) 7-day EB (n = 368), estradiol benzoate (EB) and intravaginal progesterone-(P4)-releasing device (IVPD) on Day -10, prostaglandin F_2α (PG), equine chorionic gonadotropin (eCG) and estradiol cypionate (ECP) at IVPD removal on Day -3 with FTAI done on Day -1 (54 ± 2 h after IVPD removal); II) 7-day GnRH (n = 367), GnRH at IVPD insertion on Day -10, PG and eCG at IVPD removal on Day -3 with GnRH and FTAI on Day 0 (66 ± 2 h after IVPD removal); and III) 7 & 7 GnRH (n = 361), PG at IVPD insertion on Day -17, GnRH on Day -10, IVPD removal, PG and eCG on Day -3 with GnRH and FTAI on Day 0 (66 ± 2 h after IVPD removal). Preovulatory follicle diameter, corpus luteum (CL) presence, CL area, and P4 concentration were determined at IVPD removal, as well as estrus expression at FTAI and P/AI between 35 and 40 days after FTAI. Plasma P4 concentrations at IVPD removal were greater (P < 0.05) in cows subjected to the 7-day GnRH or 7 & 7 GnRH protocols and a greater number of cows (P < 0.05) had at least one CL at IVPD removal compared to cows subjected to the 7-day EB protocol. However, the 7 & 7 GnRH protocol resulted in more cows with two CLs at IVPD removal compared to the other two protocols. Moreover, cows synchronized with the 7 & 7 GnRH protocol had larger preovulatory follicles (P < 0.05) and larger CL area at IVPD removal (P < 0.05), and a greater rate of estrus expression before FTAI (P < 0.05) than cows synchronized with the 7-day EB, whereas those variables were intermediate in cows synchronized with the 7-day GnRH. Pregnancy per AI was greater (P < 0.05) in cows treated with the 7 & 7 GnRH (63.5 %) treatment compared to the 7-day EB (51.4 %) and the 7-day GnRH (51.3 %) protocols. In summary, the 7 & 7 GnRH protocol enhanced circulating P4 before IVPD removal, increased estrus expression rate before FTAI, and improved P/AI in postpartum Bos taurus grazing beef cows.